Periodic Reporting for period 4 - MetResistance (The role of tumour microenvironment in metastatic hormone-refractory prostate cancer)

Prostate cancer (PC) is the most common malignancy in men in Europe while mHRPC is the most lethal form of the disease, causing over 95% of PC related deaths. The final period project aims to address how host cells around tumour, termed tumour microenvironment, contribute to...